Ep 99: Fatty Liver Disease and Type 2 Diabetes

Fatty liver disease can be present in up to 70% of people with type 2 diabetes–and most don't know they have it. Drs. Edelman and Pettus sit down with a hepatologist and a patient whose journey may change how you think about liver health.

Featuring Dr. Steve Edelman, Dr. Jeremy Pettus, hepatologist Dr. Julio Gutierrez, and patient advocate Manuel Oliver

Most of what shapes your long-term health doesn’t announce itself. The conditions that quietly affect millions of people with diabetes like high blood pressure, kidney disease and  fatty liver tend to develop for years before producing a single symptom. That’s exactly why being proactive about your health matters so much. Liver disease is one of those quiet conditions: deeply tied to weight, blood sugar, and metabolic health, are far more common than most people realize. Understanding the basics like what fatty liver is, how it can progress to Metabolic Dysfunction-Associated Steatohepatitis (MASH), and what tools now exist to catch it early. Why not get a head start that patients who end up with cirrhosis and or need a liver transplant often wish they had.

WATCH NOW

LISTEN TO THE EPISODE

MORE PLATFORMS

MASH STATISTICS

UP TO 70% of people with type 2 diabetes may have fatty liver disease.
UP TO 50% of people with type 2 diabetes have significant fat in the liver, which can be picked up by a simple ultrasound.
7–10% of weight loss may improve both metabolic and liver health.
LIVER SCARRING HAPPENS in 4 stages, from mild to severe (cirrhosis). The good news is that the middle stages are now treatable with FDA-approved therapies.
HIGHER PREVALENCE has been observed in Hispanic communities, possibly tied to a combination of diet, genetics, and metabolic factors.

What the Research Tells Us About MASH

  • MASH is metabolic. It develops when fat builds up in the liver and triggers inflammation and scarring, most often linked to obesity, type 2 diabetes, and metabolic syndrome.
  • It’s largely silent. Early-stage fatty liver and MASH typically produce no symptoms. By the time fatigue and other symptoms appears, the disease may already be advanced.
  • The liver can regenerate. Studies continue to show that the liver has a remarkable ability to heal when the underlying drivers like weight, blood sugar, inflammation are addressed.
  • Simple tests can flag it. A standard blood panel combined with a calculation called FIB-4 (using age, AST, ALT, and platelet count) may help estimate fibrosis risk before more invasive tests are needed.
  • Treatment options are expanding. Lifestyle changes, GLP-1 medications, and a newer class of liver-directed therapies are reshaping what’s possible including, in some cases, reversing fibrosis stages.
  • It rarely travels alone. Liver, heart, and kidney disease are increasingly understood as a connected condition (cardio-renal-hepatic-metabolic syndrome) meaning what helps improve one may help the others.

Join the Conversation

Have a question about fatty liver, MASH, or your own liver health journey? Share it in the comments below. Drs. Edelman and Pettus regularly read your questions and may answer them in a future episode.
Already navigating a fatty liver or MASH diagnosis? Tell us what you wish you'd known sooner. Your story may be the one that helps someone else catch this earlier.

Leave a Reply